A further, causative role for HIF-2α in NAFLD came from a recent study with obesity-induced hypoxia in intestinal epithelial cells where the HIF-2α-specific inhibitor PT2385 was of benefit against metabolic diseases [130]. This evidence concerns the gene EPAS1 and obesity due to melanocortin 4 receptor deficiency.